Sekri Valentin Zerrouk advised Blackout and its founders on its acquisition by 52 Entertainment
The M&A department of Sekri Valentin Zerrouk advised Blackout, a renowned casual games studio based in Barcelona, on its acquisition by 52 Entertainment, a global e-gaming leading company.
Blackout, known for its expertise in casual games development and continuous innovation, attracts over 19.6 million players each month and has achieved more than 344 million downloads, thanks to popular titles like Bubble Shooter Rainbow, Word Search Quest, and Spades. The Barcelona-based studio has carved out a significant presence in Europe, Latin America, and North America, delivering accessible, addictive games to millions of players.
With this acquisition, 52 Entertainment is extending its influence in the fast-growing casual games market, a key segment of the global gaming industry. The acquisition will enable the company to strengthen its leading position in online gaming and expand its global presence. Blackout’s market-leading products such as Spades and Bubble Shooter will add a new dimension to 52 Entertainment’s existing portfolio.
Team
Other transactions
-
Corporate
Advising the management team of Magellan Partners in connection with the arrival of ICG as a new partner
-
Corporate
Advising Upciti in a $20M Series A round led by Notion Capital
-
Corporate
Advising Isentroniq in a €7.5M fundraising round
-
Corporate
Advising Turenne Hôtellerie on the acquisition of the four-star Novotel Centre Gare Cité des Congrès hotel in Nantes
-
Corporate
Advising Goodvest in a €12M Series B funding round
-
Corporate
Advising GENEO Capital, Bpifrance and Rives Croissance as part of the sale of ConvictionsRH
-
Real estate law
Advising Bang & Olufsen in the negotiation of a commercial lease for its new flagship store in Paris
-
Corporate
Advising Genomines on the connection with a $45 million Series A financing
-
Corporate
Advising Valtus in connection with the acquisition of FS Partners in Switzerland
-
Corporate
Advising QIMA in connection with the acquisition of OxiProteomics by its QIMA Life Sciences division